169 related articles for article (PubMed ID: 30919133)
1. Optimized dual-time-window protocols for quantitative [
Heeman F; Yaqub M; Lopes Alves I; Heurling K; Berkhof J; Gispert JD; Bullich S; Foley C; Lammertsma AA;
EJNMMI Res; 2019 Mar; 9(1):32. PubMed ID: 30919133
[TBL] [Abstract][Full Text] [Related]
2. Validation of Noninvasive Tracer Kinetic Analysis of
Bullich S; Barthel H; Koglin N; Becker GA; De Santi S; Jovalekic A; Stephens AW; Sabri O
J Nucl Med; 2018 Jul; 59(7):1104-1110. PubMed ID: 29175981
[TBL] [Abstract][Full Text] [Related]
3. Simulating the effect of cerebral blood flow changes on regional quantification of [
Heeman F; Yaqub M; Lopes Alves I; Heurling K; Bullich S; Gispert JD; Boellaard R; Lammertsma AA;
J Cereb Blood Flow Metab; 2021 Mar; 41(3):579-589. PubMed ID: 32281514
[TBL] [Abstract][Full Text] [Related]
4. Parametric imaging of dual-time window [
Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive quantification of
Holy EN; Li E; Bhattarai A; Fletcher E; Alfaro ER; Harvey DJ; Spencer BA; Cherry SR; DeCarli CS; Fan AP
Res Sq; 2023 Dec; ():. PubMed ID: 38234716
[TBL] [Abstract][Full Text] [Related]
6. A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [
Kolinger GD; Vállez García D; Lohith TG; Hostetler ED; Sur C; Struyk A; Boellaard R; Koole M
EJNMMI Res; 2021 May; 11(1):49. PubMed ID: 34046730
[TBL] [Abstract][Full Text] [Related]
7. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
[TBL] [Abstract][Full Text] [Related]
8. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
Auvity S; Tonietto M; Caillé F; Bodini B; Bottlaender M; Tournier N; Kuhnast B; Stankoff B
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):490-501. PubMed ID: 31686177
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive quantification of
Holy EN; Li E; Bhattarai A; Fletcher E; Alfaro ER; Harvey DJ; Spencer BA; Cherry SR; DeCarli CS; Fan AP
EJNMMI Res; 2024 Apr; 14(1):39. PubMed ID: 38625413
[TBL] [Abstract][Full Text] [Related]
10. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
11. Impact of cerebral blood flow and amyloid load on SUVR bias.
Heeman F; Yaqub M; Hendriks J; van Berckel BNM; Collij LE; Gray KR; Manber R; Wolz R; Garibotto V; Wimberley C; Ritchie C; Barkhof F; Gispert JD; Vállez García D; Lopes Alves I; Lammertsma AA;
EJNMMI Res; 2022 May; 12(1):29. PubMed ID: 35553267
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand.
Arakawa Y; Nai Y; Shidahara M; Furumoto S; Seki C; Okamura N; Tashiro M; Kudo Y; Yanai K; Gonda K; Watabe H
J Nucl Med; 2017 Aug; 58(8):1285-1292. PubMed ID: 28062596
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.
Ikoma Y; Sasaki T; Kimura Y; Seki C; Okubo Y; Suhara T; Ito H
Ann Nucl Med; 2015 Oct; 29(8):697-708. PubMed ID: 26134215
[TBL] [Abstract][Full Text] [Related]
14. Effect of Shortening the Scan Duration on Quantitative Accuracy of [
Tuncel H; Visser D; Yaqub M; Timmers T; Wolters EE; Ossenkoppele R; van der Flier WM; van Berckel BNM; Boellaard R; Golla SSV
Mol Imaging Biol; 2021 Aug; 23(4):604-613. PubMed ID: 33496930
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
[TBL] [Abstract][Full Text] [Related]
16. Validation of a spatial normalization method using a principal component derived adaptive template for [
Leuzy A; Heurling K; De Santi S; Bullich S; Hansson O; Lilja J
Am J Nucl Med Mol Imaging; 2020; 10(4):161-167. PubMed ID: 32929394
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
18. Toward a Universal Readout for
Bischof GN; Bartenstein P; Barthel H; van Berckel B; Doré V; van Eimeren T; Foster N; Hammes J; Lammertsma AA; Minoshima S; Rowe C; Sabri O; Seibyl J; Van Laere K; Vandenberghe R; Villemagne V; Yakushev I; Drzezga A
J Nucl Med; 2021 Jul; 62(7):999-1005. PubMed ID: 33712532
[TBL] [Abstract][Full Text] [Related]
19. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
20. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol.
Snellman A; Rokka J; López-Picón FR; Eskola O; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
EJNMMI Res; 2014; 4():37. PubMed ID: 25977876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
